OBJECTIVES: The aim of this study was to determine the genetic defect in a 4-generational family with an epileptic disorder characterized by febrile and afebrile polymorphic seizures and mild to severe mental retardation by means of analyzing the neuronal voltage-gated sodium channel alpha-subunit gene SCN1A for mutations. METHODS: A Bulgarian family was ascertained and clinically assessed, followed by mutation analysis of the SCN1A gene using direct sequencing to detect point mutations and multiplex amplicon quantification to identify copy number variations. RESULTS: A microdeletion encompassing the entire SCN1A gene segregating with all affected members was identified in this family. Additional analysis showed that the unaffected father of the proband is mosaic for the deletion. So far, SCN1A deletions, predicted to lead to haploinsufficiency, are exclusively identified in isolated patients with Dravet or contiguous gene syndromes. Because of the severe phenotype, SCN1A deletion carriers are usually not able to live independently and start a family, and hence do not transmit the disease. CONCLUSIONS: We report an inherited SCN1A gene deletion not exclusively associated with Dravet syndrome. Moreover, our results demonstrate that SCN1A haploinsufficiency can cause a significant intrafamilial clinical variability including moderately affected to syndromal patients. The involvement of multiple genetic and environmental factors could be the basis of this difference in phenotype severity.
OBJECTIVES: The aim of this study was to determine the genetic defect in a 4-generational family with an epileptic disorder characterized by febrile and afebrile polymorphic seizures and mild to severe mental retardation by means of analyzing the neuronal voltage-gated sodium channel alpha-subunit gene SCN1A for mutations. METHODS: A Bulgarian family was ascertained and clinically assessed, followed by mutation analysis of the SCN1A gene using direct sequencing to detect point mutations and multiplex amplicon quantification to identify copy number variations. RESULTS: A microdeletion encompassing the entire SCN1A gene segregating with all affected members was identified in this family. Additional analysis showed that the unaffected father of the proband is mosaic for the deletion. So far, SCN1A deletions, predicted to lead to haploinsufficiency, are exclusively identified in isolated patients with Dravet or contiguous gene syndromes. Because of the severe phenotype, SCN1A deletion carriers are usually not able to live independently and start a family, and hence do not transmit the disease. CONCLUSIONS: We report an inherited SCN1A gene deletion not exclusively associated with Dravet syndrome. Moreover, our results demonstrate that SCN1Ahaploinsufficiency can cause a significant intrafamilial clinical variability including moderately affected to syndromal patients. The involvement of multiple genetic and environmental factors could be the basis of this difference in phenotype severity.
Authors: Gemma L Carvill; Krysta L Engel; Aishwarya Ramamurthy; J Nicholas Cochran; Jolien Roovers; Hannah Stamberger; Nicholas Lim; Amy L Schneider; Georgie Hollingsworth; Dylan H Holder; Brigid M Regan; James Lawlor; Lieven Lagae; Berten Ceulemans; E Martina Bebin; John Nguyen; Gregory S Barsh; Sarah Weckhuysen; Miriam Meisler; Samuel F Berkovic; Peter De Jonghe; Ingrid E Scheffer; Richard M Myers; Gregory M Cooper; Heather C Mefford Journal: Am J Hum Genet Date: 2018-12-06 Impact factor: 11.025
Authors: Moran Rubinstein; Ruth E Westenbroek; Frank H Yu; Christina J Jones; Todd Scheuer; William A Catterall Journal: Neurobiol Dis Date: 2014-10-02 Impact factor: 5.996
Authors: Michael F Hammer; Atsushi Ishii; Laurel Johnstone; Alexander Tchourbanov; Branden Lau; Ryan Sprissler; Brian Hallmark; Miao Zhang; Jin Zhou; Joseph Watkins; Shinichi Hirose Journal: PLoS One Date: 2017-07-07 Impact factor: 3.240
Authors: Iris M de Lange; Wout Weuring; Ruben van 't Slot; Boudewijn Gunning; Anja C M Sonsma; Mark McCormack; Carolien de Kovel; Lisette J J M van Gemert; Flip Mulder; Marjan J A van Kempen; Nine V A M Knoers; Eva H Brilstra; Bobby P C Koeleman Journal: Mol Genet Genomic Med Date: 2019-05-29 Impact factor: 2.183
Authors: Iris M de Lange; Flip Mulder; Ruben van 't Slot; Anja C M Sonsma; Marjan J A van Kempen; Isaac J Nijman; Robert F Ernst; Nine V A M Knoers; Eva H Brilstra; Bobby P C Koeleman Journal: Mol Genet Genomic Med Date: 2020-02-07 Impact factor: 2.183
Authors: Ana Victoria Marco Hernández; Miguel Tomás Vila; Alfonso Caro Llopis; Sandra Monfort; Francisco Martinez Journal: Front Neurol Date: 2021-11-30 Impact factor: 4.003